About
Incubate

Our Mission

Overview

Incubate is a 501(c)(4) organization of venture capital firms representing the patient, corporate, and investment communities. Our primary aim is to educate policymakers on the role of venture capital in bringing promising treatments to patients in need.

Mission

We help ensure patients continue to benefit from the unrelenting innovation spurred by venture capital investment in life sciences and protected by America’s intellectual property system.

Why venture capital matters

Learn why venture investment is so vital to developing effective new medical treatments.

Our Priorities

Foster innovation

Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.

Why It Matters

For America to remain the leader in medical innovation, its business, investment, and policy ecosystems must welcome and support life science innovators from start-ups to major firms.

Safeguard advancements

Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.

Why It Matters

Investment in life science is risky: 9 out of 10 initial treatments are ineffective or don’t recoup their development costs. Protecting the American intellectual property system preserves incentives for the development of new treatments and ensures that the revenue from successful treatments can subsidize continued innovation.

Amplify the results

Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.

Why It Matters

Amidst the nuanced discussions around healthcare costs in this country, policymakers, providers, and patients all deserve a complete understanding of the factors that contribute to successful development of effective treatments.